Skip to main content

Day: February 28, 2020

Urbanimmersive Announces Its 2020 First Quarter Financial Results

LAVAL, Quebec, Feb. 28, 2020 (GLOBE NEWSWIRE) — Urbanimmersive Inc. (“Urbanimmersive,” the “Company” or “UI”) (TSX VENTURE: UI) (OTC PINK: UBMRF) today announced select financial results and presents business highlights for the first quarter of 2020 ended December 31, 2019. The financial statements and related management’s discussion and analysis (“MD&A”) can be viewed on SEDAR at https://www.sedar.com/.HIGHLIGHTSFor Q1-20, the Company generated revenues of $601k compared to $1,260k for Q1-19, a year-over-year decrease of $659k. This decrease is mainly explained by the change of billing method for merchants from gross to net in March 2019 (-$521k) and a reduction in marketing expenses in preparation for the launch of new products such as the recently announced 3D Pocket WebsitesTM;For Q1-20, the Company recorded a gross margin...

Continue reading

Urbanimmersive annonce les résultats financiers de son premier trimestre 2020

LAVAL, Québec, 28 févr. 2020 (GLOBE NEWSWIRE) — Urbanimmersive inc. (« Urbanimmersive », la « Société » ou « UI ») (TSX CROISSANCE : UI) (OTC PINK : UBMRF) annonce aujourd’hui certains résultats financiers et présente les faits saillants des activités de son premier trimestre 2020 se terminant le 31 décembre 2019. Les états financiers intérimaires et le rapport de gestion peuvent être consultés sur SEDAR à l’adresse https://www.sedar.com/.Faits saillants :Pour son premier trimestre 2020 (Q1-20), la Société a généré des revenus totalisant 601k$ comparativement à 1 260k$ pour Q1-19, soit une diminution de 659k$, dont 521k$ s’explique par le changement du mode de facturation des marchands du brut au net en mars 2019 ainsi que par une réduction des dépenses marketing afin de préparer le lancement de nouveaux produits tel que les 3D...

Continue reading

NewLink Genetics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update

AMES, Iowa, Feb. 28, 2020 (GLOBE NEWSWIRE) — NewLink Genetics Corporation (NASDAQ:NLNK) today announced financial results for the fourth quarter and full year ended December 31, 2019, and provided an update on corporate activities.“We continue to focus our work toward the anticipated completion of our proposed merger with Lumos Pharma,” stated Carl Langren, Chief Financial Officer, and member of NewLink’s Office of the CEO. “We believe that the newly combined company will be well positioned to increase stockholder value through the continued efforts to offer improved therapeutic options for patients suffering from PGHD and other rare diseases. We look forward to the close of the merger transaction, which we expect later this quarter.”Eugene Kennedy, MD, Chief Medical Officer and member of NewLink’s Office of the CEO added, “We are...

Continue reading

Northrim BanCorp, Inc. Increases Quarterly Cash Dividend to $0.34 per Share

ANCHORAGE, Alaska, Feb. 28, 2020 (GLOBE NEWSWIRE) — Northrim BanCorp, Inc. (NASDAQ: NRIM) today announced that the Board of Directors increased its regular quarterly cash dividend to $0.34 per share.  The dividend will be payable on March 20, 2020, to shareholders of record at the close of business on March 12, 2020.“We continue to generate profitable operations, which sustains our ability to steadily increase cash dividends for the eleventh consecutive year,” said Joe Schierhorn, President and CEO.  At the stock price of $36.75 per share at the close of the market on February 27, 2020, the current dividend equates to a yield of 3.70% on an annualized basis.On January 27, 2020, Northrim reported earnings of $4.6 million, or $0.69 per diluted share, for the fourth quarter of 2019.  Return on average assets was 1.11%, return on average...

Continue reading

FLSmidth appoints Mikko Tepponen as Chief Digital Officer

FLSmidth has appointed the Finnish digitalization specialist Mikko Tepponen as new Chief Digital Officer.Coming to FLSmidth from Wärtsilä, Mikko Tepponen brings extensive knowledge in digital transformation of industrial companies. His experiences include the digital framework around topics such as product development, internal efficiencies, customer behaviour, data architecture and a digital culture. These will also be focus areas for him in FLSmidth.FLSmidth CEO Thomas Schulz looks forward to further strengthening the digital offerings of FLSmidth:“Mikko’s joining FLSmidth at this time is well-timed with the launch of our MissionZero agenda. Calling on his years of experience in automation and digital in heavy industry, he brings the right experience mix to embed digitalization and innovation into our processes; from R&D to go-to-market,...

Continue reading

Surge Components, Inc. Announces Fiscal Fourth Quarter and Full Year 2019 Results

Strong Cost Management Discipline Delivers Gross Profit Increase of 11.6% Year-Over-Year to $9.2 Million in FY 2019Robust FY 2019 Gross Profit Margins of 28.5%Company’s Challenge Division Issued Patent on New Pinpoint Alarm Designed to Improve Ability to Determine Alarm LocationFinancial Highlights for the Fiscal Year Ending November 30, 2019Net sales of $32.5 million, as compared to $32.4 million in the prior year periodGross profit of $9.2 million, a 11.6% year-over-year increase, driven by growth in sales volumes as well as certain products being sold at a higher profit margin.Gross profit margin of 28.5%, compared to 25.6% in the prior-year periodNet income available to common shareholders of $2.029 million; EPS of $0.38, compared to net income available to common shareholders of $1.956 million; EPS of $0.37 in the prior-year periodFinancial...

Continue reading

Malvern Bancorp, Inc. Announces Extension of Stock Repurchase Program

PAOLI, Pa., Feb. 28, 2020 (GLOBE NEWSWIRE) — Malvern Bancorp, Inc. (NASDAQ: MLVF) (the “Company”), parent company of Malvern Bank, National Association (“Malvern” or the “Bank”), today announced that its board of directors has extended the timeframe for its current stock repurchase program, previously announced on March 14, 2019, from March 31, 2020 to December 31, 2020.When the current program was previously announced, the Company planned to repurchase up to 194,516 shares, or approximately 2.5% of the current outstanding common stock. To date, the Company has repurchased 16,863 of these shares at an average cost of $19.95 per share, leaving 177,653 shares, or approximately 2.3% of the current outstanding stock, still available for repurchase.The Company currently has approximately 7.782 million shares of common stock outstanding....

Continue reading

Cowen Outsourced Trading Wins 2020 Hedgeweek Annual Global Award

NEW YORK, Feb. 28, 2020 (GLOBE NEWSWIRE) — Cowen Inc. (NASDAQ:COWN) (“Cowen” or the “Company”) today announced that its global Outsourced Trading group was recognized as the “Best Outsourced Trading Provider” at the 2020 Hedgeweek Global Awards event. The criteria for the awards were based on an online peer review system in which managers, fund administrators, prime brokers, custodians and advisers were invited to elect “best in class” in a variety of categories.Upon winning the award for the second year in a row, Bobby Croswell, Managing Director, Outsourced Trading, said, “We’re honored to be recognized yet again by Hedgeweek and our peers in the industry as ‘Best Outsourced Trading Provider’. This award validates our continued commitment to providing reliable, secure and innovative service and solutions to support our clients....

Continue reading

Celsion Corporation Prices $4.8 Million Registered Direct Offering

LAWRENCEVILLE, NJ, Feb. 28, 2020 (GLOBE NEWSWIRE) — Celsion Corporation (NASDAQ: CLSN) (“Celsion” or the “Company”), today announced it has entered into securities purchase agreements with institutional investors for the purchase and sale of 4,571,428 shares of the Company’s common stock, par value $0.01 per share, pursuant to a registered direct offering. The Company has also agreed to issue to such investors, in a concurrent private placement, warrants to purchase 2,971,428 shares of the Company’s common stock. The warrants will be exercisable on the six-month anniversary of the issuance date, will expire on the five-year anniversary of the initial exercise date and have an exercise price of $1.15 per share. The gross proceeds of the offering will be approximately $4.8 million before deducting placement agent fees and other estimated...

Continue reading

Medexus Expands its US Product Portfolio by Acquiring the Hematology Asset IXINITY®

Acquisition Expected to be Immediately Accretive to Adjusted EBITDA1Announces US$20 Million Credit Facility with MidCap FinancialTORONTO and CHICAGO and MONTREAL, Feb. 28, 2020 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSXV: MDP, OTCQB: PDDPF) today announced that the Company, through its US-based subsidiary, acquired Aptevo BioTherapeutics LLC, a Delaware limited liability company owning the worldwide rights to the commercial hematology asset, IXINITY®, from Aptevo Therapeutics, Inc. (NASDAQ: APVO) (the “Vendor”), a biotechnology company focused on developing oncology, autoimmune and hematology therapeutics (the “Acquisition”). IXINITY® is an intravenous recombinant factor IX therapeutic for use in patients 12 years of age or older with Hemophilia B – a hereditary bleeding disorder characterized...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.